BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12656688)

  • 1. Review article: pruritus in cholestatic and other liver diseases.
    Mela M; Mancuso A; Burroughs AK
    Aliment Pharmacol Ther; 2003 Apr; 17(7):857-70. PubMed ID: 12656688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
    Matsuzaki Y
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cholestatic pruritus in children.
    Cies JJ; Giamalis JN
    Am J Health Syst Pharm; 2007 Jun; 64(11):1157-62. PubMed ID: 17519457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Chronic Hepatic Itch.
    Düll MM; Kremer AE
    Dermatol Clin; 2018 Jul; 36(3):293-300. PubMed ID: 29929600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiopathology and management of cholestatic pruritus in children].
    Thébaut A; Debray D; Gonzales E
    Arch Pediatr; 2017 Jul; 24(7):682-688. PubMed ID: 28583778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestatic Itch Management.
    Mittal A
    Curr Probl Dermatol; 2016; 50():142-8. PubMed ID: 27578083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pruritus in chronic cholestatic liver disease.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2012 May; 16(2):331-46. PubMed ID: 22541702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of cholestatic pruritus.
    Bolier AR; Peri S; Oude Elferink RP; Beuers U
    Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch Management: Systemic Agents.
    Pongcharoen P; Fleischer AB
    Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pruritus associated with cholestasis. A review of pathogenesis and management.
    Khandelwal M; Malet PF
    Dig Dis Sci; 1994 Jan; 39(1):1-8. PubMed ID: 8281842
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pruritus associated with cholestasis].
    Terán A; Fábrega E; Pons-Romero F
    Gastroenterol Hepatol; 2010 Apr; 33(4):313-22. PubMed ID: 19836105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of itching associated with intrahepatic cholestasis of pregnancy.
    Jenkins JK; Boothby LA
    Ann Pharmacother; 2002 Sep; 36(9):1462-5. PubMed ID: 12196068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and treatment of pruritus in cholestasis.
    Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
    Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pathogenesis and treatment of pruritus.
    Bolier R; Oude Elferink RP; Beuers U
    Clin Liver Dis; 2013 May; 17(2):319-29. PubMed ID: 23540505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pruritus and fatigue associated with liver disease: is there a role for ondansetron?
    Jones EA
    Expert Opin Pharmacother; 2008 Mar; 9(4):645-51. PubMed ID: 18312165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis and treatment of pruritus in patients with cholestasis].
    Schirrmacher S; Blumenstein I; Stein J
    Z Gastroenterol; 2003 Mar; 41(3):259-62. PubMed ID: 12664347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of intrahepatic cholestasis of pregnancy.
    Marschall HU
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1273-9. PubMed ID: 26313609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pruritus in pregnancy and obstetric cholestasis.
    Clark TJ; Dwarakanath L; Weaver JB
    Hosp Med; 1999 Apr; 60(4):254-60. PubMed ID: 10396430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.